HEOR (Health Economics and Outcomes Research) data modelling at phamax is the triangulation of information like epidemiology, disease burden, and new intervention costs with Budget Impact Modelling, Cost-effectiveness Analysis, and Disease Burden Analysis.
In HEOR data modelling, we assess the impact of the new intervention on the overall healthcare budget, burden of disease as DALYs (Disability-Adjusted Life Year), resource utilization and impact (direct and indirect) on the economy, as well as the cost–benefit of the product over the current therapy.
We provide comprehensive tools to effectively demonstrate and communicate the cost-saving potential (budget optimization). phamax also supports payers to prioritize treatments for inclusion in the reimbursement list and plans the research and development.
Triangulation of information like epidemiology, disease burden, and new intervention costs with: